Study S001045
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Registration
Registered primary outcomes
- Gastric Emptying of Solids Half-time (T1/2) at 5 Weeks [5 weeks]
- Gastric Emptying of Solids Half-time (T1/2) at 16 Weeks [16 weeks]
Linked records (4)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
| Record | Title | Year | Design | Identifiers | Link basis |
|---|---|---|---|---|---|
| R0000439 | Appetite Suppression by GLP-1 Receptor Agonists: Role of Delayed Gastric Emptying. Friedman MI, Obesity (Silver Spring, Md.) | 2026 | Randomized trial | PMID 42392577DOI | cites ClinicalTrials.gov:NCT02647944; registry reference DERIVED:42392577 |
| R0016746 | Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial. Maselli D, Obesity (Silver Spring, Md.) | 2022 | Randomized trial | PMID 35894080DOI | cites ClinicalTrials.gov:NCT02647944; registry reference DERIVED:35894080 |
| R0019135 | GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity. Kadouh H, The Journal of clinical endocrinology and metabolism | 2020 | Randomized trial | PMID 31665455DOI | cites ClinicalTrials.gov:NCT02647944; registry reference DERIVED:31665455 |
| R0022992 | Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Halawi H, The lancet. Gastroenterology & hepatology | 2017 | Randomized trial | PMID 28958851DOI | cites ClinicalTrials.gov:NCT02647944; registry reference BACKGROUND:28958851 |